These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 12888921

  • 1. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1.
    Gagnon V, St-Germain ME, Parent S, Asselin E.
    Int J Oncol; 2003 Sep; 23(3):803-10. PubMed ID: 12888921
    [Abstract] [Full Text] [Related]

  • 2. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E.
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [Abstract] [Full Text] [Related]

  • 3. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
    St-Germain ME, Gagnon V, Parent S, Asselin E.
    Mol Cancer; 2004 Mar 11; 3():7. PubMed ID: 15016316
    [Abstract] [Full Text] [Related]

  • 4. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
    Gagnon V, Mathieu I, Sexton E, Leblanc K, Asselin E.
    Gynecol Oncol; 2004 Sep 11; 94(3):785-95. PubMed ID: 15350374
    [Abstract] [Full Text] [Related]

  • 5. PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
    Tang LL, Yokoyama Y, Wan X, Iwagaki S, Niwa K, Tamaya T.
    Oncol Rep; 2006 Apr 11; 15(4):855-9. PubMed ID: 16525671
    [Abstract] [Full Text] [Related]

  • 6. Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells.
    Lilja JF, Wu D, Reynolds RK, Lin J.
    Anticancer Res; 2001 Apr 11; 21(3B):1969-74. PubMed ID: 11497285
    [Abstract] [Full Text] [Related]

  • 7. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP, Smith WM, Dahia PL, Ziebold U, Gil E, Lees JA, Eng C.
    Cancer Res; 1999 Nov 15; 59(22):5808-14. PubMed ID: 10582703
    [Abstract] [Full Text] [Related]

  • 8. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
    Kanamori Y, Kigawa J, Itamochi H, Shimada M, Takahashi M, Kamazawa S, Sato S, Akeshima R, Terakawa N.
    Clin Cancer Res; 2001 Apr 15; 7(4):892-5. PubMed ID: 11309338
    [Abstract] [Full Text] [Related]

  • 9. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E, Mills GB, Tsang BK.
    Cancer Res; 2001 Mar 01; 61(5):1862-8. PubMed ID: 11280739
    [Abstract] [Full Text] [Related]

  • 10. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM, Tazzari PL, Tabellini G, Bortul R, Billi AM, Manzoli L, Ruggeri A, Conte R, Cocco L.
    Leukemia; 2003 Sep 01; 17(9):1794-805. PubMed ID: 12970779
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX, Xu XX, Tan BZ, Zhang Z, Zhou XD.
    Cell Physiol Biochem; 2017 Sep 01; 41(3):933-946. PubMed ID: 28222438
    [Abstract] [Full Text] [Related]

  • 12. Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells.
    Wang Q, Wang X, Hernandez A, Hellmich MR, Gatalica Z, Evers BM.
    J Biol Chem; 2002 Sep 27; 277(39):36602-10. PubMed ID: 12140294
    [Abstract] [Full Text] [Related]

  • 13. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
    Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H.
    J Biol Chem; 2001 Mar 30; 276(13):9817-24. PubMed ID: 11139588
    [Abstract] [Full Text] [Related]

  • 14. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y, Zhang J, Murga C, Yu H, Koller E, Monia BP, Gutkind JS, Li W.
    Oncogene; 2002 Aug 08; 21(34):5289-300. PubMed ID: 12149650
    [Abstract] [Full Text] [Related]

  • 15. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
    Fan S, Ma YX, Gao M, Yuan RQ, Meng Q, Goldberg ID, Rosen EM.
    Mol Cell Biol; 2001 Aug 08; 21(15):4968-84. PubMed ID: 11438654
    [Abstract] [Full Text] [Related]

  • 16. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
    Kandasamy K, Srivastava RK.
    Cancer Res; 2002 Sep 01; 62(17):4929-37. PubMed ID: 12208743
    [Abstract] [Full Text] [Related]

  • 17. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
    Chen X, Thakkar H, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK.
    Oncogene; 2001 Sep 20; 20(42):6073-83. PubMed ID: 11593415
    [Abstract] [Full Text] [Related]

  • 18. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE, Franke TF, Moroni M, Mueller S, Morgan E, Iann MC, Winder AD, Reiter R, Wellstein A, Martin MB, Stoica A.
    Oncogene; 2003 Sep 11; 22(39):7998-8011. PubMed ID: 12970748
    [Abstract] [Full Text] [Related]

  • 19. Growth and activation of PI-3K/PKB and Akt by stromal cell-derived factor 1alpha in endometrial carcinoma cells with expression of suppressor endoprotein PTEN.
    Li XP, Zhao D, Gao M, Zhao C, Wang JL, Wei LH.
    Chin Med J (Engl); 2006 Mar 05; 119(5):378-83. PubMed ID: 16542580
    [Abstract] [Full Text] [Related]

  • 20. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
    Lee S, Choi EJ, Jin C, Kim DH.
    Gynecol Oncol; 2005 Apr 05; 97(1):26-34. PubMed ID: 15790433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.